Back to Search Start Over

KIR3DL2 MUTATION MAY DEFINE A HIGH RATE OF RESPONSE OF AITL TO TIPIFARNIB.

Authors :
Gualberto, A.
Scholz, C.
Mishra, V.
Kessler, L.
Rodriguez, M.
Piris, M.
Witzig, T.
Source :
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p204-204, 1p
Publication Year :
2019

Subjects

Subjects :
CANCER treatment
T-cell lymphoma
STOCK ownership
NUCLEOTIDE sequence
KILLER cells

Details

Language :
English
ISSN :
02780232
Volume :
37
Database :
Complementary Index
Journal :
Hematological Oncology
Publication Type :
Academic Journal
Accession number :
137029243
Full Text :
https://doi.org/10.1002/hon.20_2630
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details